These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5376998)

  • 41. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evidence of a reduction of insulin secretion in diabetes with or without obesity. Discussion of the therapeutic use of biguanides].
    Luyckx A; Lefebvre P
    Ann Endocrinol (Paris); 1969; 30(6):717-30. PubMed ID: 5384987
    [No Abstract]   [Full Text] [Related]  

  • 43. Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate.
    Forcheron F; Basset A; Del Carmine P; Beylot M
    Diabetes Metab; 2009 Dec; 35(6):452-7. PubMed ID: 19854668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
    Vague P; Vague J
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
    [No Abstract]   [Full Text] [Related]  

  • 45. The pathogenesis of diabetes mellitus.
    Clarke BF
    Scott Med J; 1970 Sep; 15(9):339-51. PubMed ID: 4319634
    [No Abstract]   [Full Text] [Related]  

  • 46. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sitagliptin and metformin--novel combination therapy.
    Seyoum B
    Expert Opin Pharmacother; 2011 Mar; 12(4):641-6. PubMed ID: 21291346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The insulin sparing effect of metformin in insulin-treated diabetic patients.
    Slama G
    Diabete Metab; 1991 May; 17(1 Pt 2):241-3. PubMed ID: 1834486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Does insulin resistance present a significant problem in type 2 diabetes?].
    Glaser B; Leibovitch G; Nesher R; Cerasi E
    Harefuah; 1986 Nov; 111(10):330-3. PubMed ID: 3546012
    [No Abstract]   [Full Text] [Related]  

  • 51. [Proceedings: Changes in endogenous insulin secretion caused by insulin therapy: observation on monocomponent (MC) insulin therapy].
    Fukumoto Y; Ichihara K; Tarui S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):214. PubMed ID: 4476352
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hypoglycemia-induced inhibition of insulin secretion in metabolically healthy subjects, in diabetics and in patients with adrenalectomy].
    Krause U; Faisst G; Cordes U; Beyer J
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1391-3. PubMed ID: 611850
    [No Abstract]   [Full Text] [Related]  

  • 53. Factors controlling release of insulin from beta cell in relation to diabetes mellitus.
    Romanoff NE
    N Y State J Med; 1968 Feb; 68(3):385-91. PubMed ID: 4865846
    [No Abstract]   [Full Text] [Related]  

  • 54. [ATTEMPTED THERAPY OF SEVERE FORMS OF DIABETES MELLITUS WITH A BIGUANIDE PREPARATION "GLUCOPHAGE" (LA 6023)].
    MICULINIC R; JAKSIC Z; SKRABALO Z
    Lijec Vjesn; 1963 Nov; 85():1279-86. PubMed ID: 14097629
    [No Abstract]   [Full Text] [Related]  

  • 55. [Inheritance of diabetes mellitus].
    Puchulu FE; Ruiz M
    Prensa Med Argent; 1972 Jun; 59(21):808-14. PubMed ID: 4559519
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of zinc chelate on the secretion of insulin.
    Kruse-Jarres JD; Grohmann KJ; Klingmüller V
    Isr J Med Sci; 1972 Jun; 8(6):752. PubMed ID: 4559413
    [No Abstract]   [Full Text] [Related]  

  • 57. [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
    Satoh J
    Nihon Rinsho; 2003 Jul; 61(7):1224-9. PubMed ID: 12877089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 59. [Insulin secretion during primo-insulin therapy of diabetes resistant to oral drugs].
    Orsetti A; Mirouze J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():311-8. PubMed ID: 5376990
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
    Rissanen A; Howard CP; Botha J; Thuren T;
    Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.